Etiometry Adds Waveform Data Collection Capabilities to Capture High-Frequency Data in the ICU

Enables the Etiometry Platform to Capture High-Resolution Waveform Data to Further Support Biomedical Research Boston, March 27, 2018—Etiometry, a pioneering leader in next-generation patient monitoring, has added waveform capabilities to the Etiometry Platform. The company’s T3 Data Aggregation & Visualization software is now able to capture high-resolution waveform data from medical devices deployed throughout the ICU. Medical researchers can leverage T3 to capture high-frequency biomedical device data to gain further…

Study Finds Hospitals Reduce Pediatric Patient Length of Stay by 25% by Deploying Etiometry Risk Analytics

Results of a Multi-Center, Retrospective Cohort Analysis of All Neonates Admitted to the CICU at Boston Children’s Hospital and the Hospital for Sick Children, Toronto Boston, December 19, 2017—Etiometry, a pioneering leader in next-generation patient monitoring, announced today that a study presented in the American Heart Association (AHA) Scientific Sessions 2017 demonstrates the capability of the Etiometry Platform to significantly reduce hospitals intensive care unit costs. The Impact of a…

Etiometry Receives FDA 510(k) Clearance to Expand the Indications on Its IDO2 Index Powered by Risk Analytics

Hospitals Can Expand the Intelligent Monitoring Provided by Etiometry’s Inadequate Oxygen Delivery Index to Patients Up to 12 Years of Age BOSTON, June 12, 2017— Etiometry, a pioneering leader in next-generation patient monitoring, has received FDA Clearance for its Inadequate Oxygen Delivery (IDO2) Index for monitoring ICU patients 12 years or younger. Originally cleared by the FDA in 2016 for tracking the clinical risk of inadequate oxygen delivery to neonatal…